EPISODE · Nov 22, 2024 · 18 MIN
AMP 2024: Trends and Insights from Vancouver
from IPM’s insider coverage of the AMP meeting
Inside Precision Medicine’s VP and publisher Bill Levine joins North American Editor Jonathan D. Grinstein, PhD, for a recap of how the molecular pathology community—from clinical labs and health systems to the biopharma industry—is reacting to the FDA’s ruling on laboratory-developed tests (LDTs), integrating advancements in digital pathology and precision medicine into clinical care, and more.Produced by Bill LevineHosted by Jonathan D. GrinsteinMusic provided by Oleksii HolubievAudio mixed and mastered by Jason Mack Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
Inside Precision Medicine’s VP and publisher Bill Levine joins North American Editor Jonathan D. Grinstein, PhD, for a recap of how the molecular pathology community—from clinical labs and health systems to the biopharma industry—is reacting to the FDA’s ruling on laboratory-developed tests (LDTs), integrating advancements in digital pathology and precision medicine into clinical care, and more.Produced by Bill LevineHosted by Jonathan D. GrinsteinMusic provided by Oleksii HolubievAudio mixed and mastered by Jason Mack Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
AMP 2024: Trends and Insights from Vancouver
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m